Current application and research directions for partial-breast irradiation

Sharad Goyal, Thomas Kearney, Bruce Haffty

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations

Abstract

Breast-conservation therapy (BCT), consisting of lumpectomy followed by whole-breast irradiation (WBI), is the standard of care for women with early-stage breast cancer. However, many women who are candidates for BCT either choose mastectomy or lumpectomy alone for myriad reasons. Accelerated partial-breast irradiation (APBI) is a collection of radiotherapy techniques that deliver higher daily doses of radiation to the surgical cavity with margin over a shorter time than WBI, reducing total treatment time from 6-6.5 weeks to 1-2 weeks. Advocates of APBI state that early results of this approach demonstrate excellent local control, minimal acute toxicity, and are associated with more convenience for the patient. Phase III randomized clinical trials are currently underway to assess local control, acute and chronic toxicities, and quality of life associated with APBI compared to WBI. In this review, we hope to clarify the rationale behind APBI and discuss in depth data concerning various partial-breast irradiation techniques that are being used throughout the United States and around the world.

Original languageEnglish (US)
Pages (from-to)449-461
Number of pages13
JournalOncology
Volume21
Issue number4
StatePublished - Apr 1 2007

All Science Journal Classification (ASJC) codes

  • Oncology

Fingerprint Dive into the research topics of 'Current application and research directions for partial-breast irradiation'. Together they form a unique fingerprint.

Cite this